44 results
PRE 14A
kf9j0l30jtffe72qg3
18 Apr 23
Preliminary proxy
4:30pm
8-K
EX-99.2
vnxcol3ms
9 Aug 22
Zentalis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update
12:00am
8-K
EX-99.2
3yhvz 300g0rpfucn
8 Apr 22
Zentalis Pharmaceuticals Announces Positive Initial Clinical Data on ZN-c3, its Wee1 Inhibitor, in Patients with Advanced Ovarian Cancer at AACR
5:05pm
DEF 14A
8ffz6
23 Apr 21
Definitive proxy
4:05pm